Multifunctional scutellarin–rivastigmine hybrids with cholinergic, antioxidant, biometal chelating and neuroprotective properties for the treatment of Alzheimer’s disease-Reference-Cited by-同舟云学术

Multifunctional scutellarin–rivastigmine hybrids with cholinergic, antioxidant, biometal chelating and neuroprotective properties for the treatment of Alzheimer’s disease

Published:2015-02 Issue:4 Volume:23 Page:668-680
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Sang Zhipei,Li Yan,Qiang Xiaoming,Xiao Ganyuan,Liu Qiang,Tan Zhenghuai,Deng Yong

Funder

Chinese National Natural Science Foundation

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference28 articles.

1. Serotonin 5-HT6 Receptor Antagonists for the Treatment of Cognitive Deficiency in Alzheimer’s Disease

2. Design, Synthesis, and Evaluation of Multitarget-Directed Resveratrol Derivatives for the Treatment of Alzheimer’s Disease

3. Current and Emerging Drug Treatment Options for Alzheimerʼs Disease

4. Novel tacrine–ebselen hybrids with improved cholinesterase inhibitory, hydrogen peroxide and peroxynitrite scavenging activity

5. Carbamate Derivatives of Indolines as Cholinesterase Inhibitors and Antioxidants for the Treatment of Alzheimer’s Disease

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual-target inhibitors based on acetylcholinesterase: Novel agents for Alzheimer's disease;European Journal of Medicinal Chemistry;2024-12

2. Efficient synthesis and evaluation of therapeutic potential of fluorine containing 2-arylchromen-4-ones;Molecular Diversity;2024-07-16

3. Review on the pharmacological effects and pharmacokinetics of scutellarein;Archiv der Pharmazie;2024-06-07

4. Innovative approaches to Alzheimer's therapy: Harnessing the power of heterocycles, oxidative stress management, and nanomaterial drug delivery system;Ageing Research Reviews;2024-06

5. 3D QSAR, Molecular Docking, and ADMET Studies of a Series of 2-Acetylphenol-Rivastigmine Hybrids against Monoamine Oxidase A Inhibitors;PHYS CHEM RES;2024